Pomalidomide-PEG2-CH2COOH CAS:2143097-05-4 is a type of small molecule drug that is used in the treatment of certain types of cancer, particularly multiple myeloma. It is composed of several functional groups, including a pomalidomide group, a polyethylene glycol (PEG) spacer, and a carboxylic acid group.
Pomalidomide is a type of immunomodulatory drug that has been shown to be effective in treating multiple myeloma, a type of cancer that affects the bone marrow. The PEG spacer in Pomalidomide-PEG2-CH2COOH is used to improve the solubility and stability of the drug in solution, allowing it to be more easily administered to patients. The carboxylic acid group is important for the chemical reactivity and solubility of the compound.
In terms of its mechanism of action, Pomalidomide-PEG2-CH2COOH works by modulating the activity of certain immune cells in the body, particularly T cells and natural killer cells. By enhancing the activity of these cells, Pomalidomide-PEG2-CH2COOH can help to boost the body’s immune response to cancer cells, leading to improved outcomes for patients with multiple myeloma.
Pomalidomide-PEG2-CH2COOH represents an important advance in the treatment of multiple myeloma and other types of cancer. By targeting specific immune cells and enhancing the body’s natural defenses against cancer, this drug has shown significant promise in improving outcomes for patients and extending their lives.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
